Revvity Signals Software: Accelerating Scientific Breakthroughs
Enterprise software solutions that help scientists make smarter decisions to develop more effective products and treatments to enable life-changing scientific breakthroughs.
Our complex world is moving at an extraordinary pace and it’s not enough that scientists react to it, but they must anticipate the impact of our environment on people’s lives every day with revolutionary breakthroughs, scientific discoveries, and life-changing therapies.
That’s where Revvity Signals Software comes in.
Our modern software solutions, developed with decades of experience, accelerate research and development, and facilitate innovation.
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.